NasdaqGS - Nasdaq Real Time Price USD
Aclaris Therapeutics, Inc. (ACRS)
1.1800
-0.0400
(-3.28%)
At close: May 14 at 4:00:01 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
220,327
197,405
254,596
251,211
Total Liabilities Net Minority Interest
64,773
40,226
56,975
53,870
Total Equity Gross Minority Interest
155,554
157,179
197,621
197,341
Total Capitalization
155,554
157,179
197,621
197,341
Common Stock Equity
155,554
157,179
197,621
197,341
Capital Lease Obligations
--
426
684
693
Net Tangible Assets
155,554
157,179
190,648
190,293
Working Capital
94,355
97,904
209,612
182,101
Invested Capital
155,554
157,179
197,621
197,341
Tangible Book Value
155,554
157,179
190,648
190,293
Total Debt
--
426
684
693
Share Issued
107,850.1240
70,894.8890
66,688.6470
61,228.4460
Ordinary Shares Number
107,850.1240
70,894.8890
66,688.6470
61,228.4460
Treasury Shares Number
--
0
--
--
12/31/2021 - 10/6/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVBP ArriVent BioPharma, Inc.
18.75
-1.83%
ERAS Erasca, Inc.
1.2700
-4.51%
PSTV Plus Therapeutics, Inc.
0.5301
-24.05%
ACRV Acrivon Therapeutics, Inc.
1.1400
+0.88%
ANTX AN2 Therapeutics, Inc.
1.1900
+0.85%
ENTA Enanta Pharmaceuticals, Inc.
5.18
-0.96%
AVTX Avalo Therapeutics, Inc.
3.6000
-2.17%
PMVP PMV Pharmaceuticals, Inc.
0.8458
-0.75%
ADVM Adverum Biotechnologies, Inc.
2.0600
-7.00%
GHRS GH Research PLC
9.98
-0.80%